Proceedings of the National Academy of Sciences · 2008 · 199 citations · 21 references
Life SciencesCell BiologyImmunologyCell SignalingCellular ImmunologySignal TransductionCytokine BiologyDendritic Cell BiologyDendritic Cell RegulationImmune Cell DifferentiationImmune Cell SignalingMajor Histocompatibility ComplexConventional Dendritic Cell DifferentiationDendritic Cell SignalingDendritic Cell Tolerogenic FunctionDendritic Cell TolerogenicityMhc Class Ii MoleculesReceptorsTolerogenic Dendritic CellsTransgenic Mice
The expression of Ig-like transcript (ILT) inhibitory receptors is a characteristic of tolerogenic dendritic cells (DCs). However, the mechanisms of modulation of DCs via ILT receptors remain poorly defined. HLA-G is a preferential ligand for several ILTs. Recently, we demonstrated that triggering of ILT4 by HLA-G1 inhibits maturation of human monocyte-derived conventional DCs and murine DCs from ILT4 transgenic mice, resulting in diminished expression of MHC class II molecules, CD80 and CD86 costimulatory molecules, and prolongation of skin allograft survival. Different isoforms of HLA-G have diverse effects on the efficiency to induce ILT-mediated signaling. In this work, we show that HLA-G1 tetrameric complex and HLA-G5 dimer, but not HLA-G5 monomer, induce strong ILT-mediated signaling. We determined that the arrest of maturation of ILT4-positive DCs by HLA-G ligands involves the IL-6 signaling pathway and STAT3 activation. Ligation of ILT4 with HLA-G on DCs results in recruitment of SHP-1 and SHP-2 protein tyrosine phosphatases. We propose a model where SHP-2 and the IL-6-STAT3 signaling pathway play critical roles in the modulation of DC differentiation by ILT4 and HLA-G.
21
Activation of NK Cells by an Endocytosed Receptor for Soluble HLA-G
Sumati Rajagopalan, Yenan T. Bryceson, Shanmuga P Kuppusamy et al. · PLoS Biology · 2005 · 350 citations · Full text